A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 105.22
GOOG 539.78
MSFT 46.13
BAC 16.72
FB 80.67

Recently Added

BBRY 10.26
CMRE 19.85
NCLH 35.02
EXPR 14.09
ANF 31.69

Gaining Speed

CMRE 19.85
TRGP 127.34
TRP 48.40
NCLH 35.02
EXPR 14.09

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!